Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-26092025-266438
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 4220]
NEW DELHI, TUESDAY, SEPTEMBER 23, 2025/ASVINA 1, 1947
6359 GI/2025
[F. No. X.11035/125/2024-DR]
NIKHIL GAJRAJ, Jt. Secy.
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi, the 23rd September, 2025
S.O. 4338(E).—WHEREAS, the Central Government has published a draft notification, in exercise of the
powers conferred by section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940), vide notification of the
Government of India in the Ministry of Health and Family Welfare (Department of Health and Family Welfare)
number S.O. 2298 (E), dated the 22nd May, 2025, in the Gazette of India, Extraordinary, Part II, section 3, sub-section
(ii), inviting objections and suggestions from persons likely to be affected thereby, before the expiry of a period of
thirty days from the date on which the copies of the Gazette of India containing these draft notification are made
available to the public;
AND WHEREAS, copies of the said Official Gazette were made available to the public on the 22nd May,
2025;
AND WHEREAS, no objections and suggestions were received from the public on the said rules;
AND WHEREAS, safer alternatives to the said drugs for animal use are available;
AND WHEREAS, the Central Government is satisfied that it is necessary and expedient in the public interest
to prohibit the import, manufacture, sale, and distribution of any antimicrobial medicinal products for animal use as
specified in this notification;
Now, therefore in exercise of the powers conferred by sections 10A & 26A of the Drugs and Cosmetics Act,
1940 (23 of 1940), after consultation with the Drugs Technical Advisory Board, the Central Government hereby
prohibit the import, manufacture, sale and distribution of the following antimicrobials and group of such
antimicrobials and their formulations for animal use namely: -
1. Antibiotics
i. Ureidopenicillins
ii. Ceftobiprole
iii. Ceftaroline
iv. Siderophore cephalosporins
v. Carbapenems
vi. Penems
vii. Monobactams
viii. Glycopeptides
ix. Lipopeptides
x. Oxazolidinones
xi. Fidaxomicin
xii. Plazomicin
xiii. Glycylcyclines
xiv. Eravacycline
xv. Omadacycline
2. Antivirals
i. Amantadine
ii. Baloxavir marboxil
iii. Celgosivir
iv. Favipiravir
v. Galidesivir
vi. Lactimidomycin
vii. Laninamivir
viii. Methisazone/ Metisazone
ix. Molnupiravir
x. Nitazoxanide
xi. Oseltamivir
xii. Peramivir
xiii. Ribavirin
xiv. Rimantadine
xv. Tizoxanide
xvi. Triazavirin
xvii. Umifenovir
xviii. Zanamivir
3. Antiprotozoals
Nitazoxanide
[F. No. X.11035/125/2024-DR]
NIKHIL GAJRAJ, Jt. Secy.
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054. GORAKHA NATH
YADAVA